|
Volumn 43, Issue 4, 2011, Pages 1013-1016
|
"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ADULT;
ASSAY;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CREATININE BLOOD LEVEL;
CYTOMEGALOVIRUS;
GRAFT REJECTION;
HUMAN;
IMMUNE FUNCTION TEST;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
KIDNEY TRANSPLANTATION;
MEASUREMENT;
PRIORITY JOURNAL;
VIRUS REPLICATION;
ADENOSINE TRIPHOSPHATE;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
BIOLOGICAL MARKERS;
CD4-POSITIVE T-LYMPHOCYTES;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNOSUPPRESSIVE AGENTS;
ITALY;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MONITORING, IMMUNOLOGIC;
MYCOPHENOLIC ACID;
PILOT PROJECTS;
PREDICTIVE VALUE OF TESTS;
RECOMBINANT FUSION PROTEINS;
RISK ASSESSMENT;
RISK FACTORS;
STEROIDS;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
VIRUS DISEASES;
|
EID: 79957626523
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.02.043 Document Type: Conference Paper |
Times cited : (23)
|
References (7)
|